Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hyperuricemia 1 Fallopian Tube Neoplasms 1 Congenital Abnormalities 1 Carcinoma, Ovarian Epithelial 1 Burkitt Lymphoma 1 Blast Crisis 1

Interventions

rasburicase 2 Urate Oxidase 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hyperuricemia × Allopurinol × Clear all

NCT00607152 2014-05-08

Rasburicase (Fasturtec) Registration Trial

Sanofi

Phase 3 Terminated

Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡